Nippon Shinyaku Co., Ltd. (4516) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

933.5 k

Shareholding (Mar 2015)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.48%

Healthy long term growth as Net Sales has grown by an annual rate of 6.56% and Operating profit at 11.15%
Company has very low debt and has enough cash to service the debt requirements

With ROE of 13.18%, it has a very attractive valuation with a 1.00 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 231,408 Million (Small Cap)

P/E

8.00

Industry P/E

Dividend Yield

0.02%

Debt Equity

-0.23

Return on Equity

12.14%

Price to Book

0.92

Revenue and Profits:

Net Sales:

39,546 Million

(Quarterly Results - Jun 2025)

Net Profit:

8,256 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

75.69%

6 Months

63.5%

1 Year

37.22%

2 Years

15.69%

3 Years

-26.63%

4 Years

-28.27%

5 Years

-19.94%

Nippon Shinyaku Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.56%

EBIT Growth (5y)

11.15%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

0.67

Tax Ratio

9.89%

Dividend Payout Ratio

25.65%

Pledged Shares

Institutional Holding

3.50%

ROCE (avg)

22.88%

ROE (avg)

12.48%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.00

EV to EBIT

5.23

EV to EBITDA

4.49

EV to Capital Employed

1.00

EV to Sales

1.20

PEG Ratio

0.29

Dividend Yield

0.01%

ROCE (Latest)

19.04%

ROE (Latest)

13.18%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2015

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.63% vs -7.33% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 106.19% vs -67.12% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39,546.00",
          "val2": "38,912.00",
          "chgp": "1.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12,299.00",
          "val2": "6,857.00",
          "chgp": "79.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "46.00",
          "val2": "56.00",
          "chgp": "-17.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,256.00",
          "val2": "4,004.00",
          "chgp": "106.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "270.70%",
          "val2": "137.80%",
          "chgp": "13.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.08% vs 2.83% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 25.94% vs 13.30% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "160,232.00",
          "val2": "148,255.00",
          "chgp": "8.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42,779.00",
          "val2": "36,409.00",
          "chgp": "17.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "102.00",
          "val2": "57.00",
          "chgp": "78.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-892.00",
          "val2": "-994.00",
          "chgp": "10.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32,560.00",
          "val2": "25,853.00",
          "chgp": "25.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "229.40%",
          "val2": "211.70%",
          "chgp": "1.77%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

39,546.00

38,912.00

1.63%

Operating Profit (PBDIT) excl Other Income

12,299.00

6,857.00

79.36%

Interest

46.00

56.00

-17.86%

Exceptional Items

0.00

Consolidate Net Profit

8,256.00

4,004.00

106.19%

Operating Profit Margin (Excl OI)

270.70%

137.80%

13.29%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.63% vs -7.33% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 106.19% vs -67.12% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

160,232.00

148,255.00

8.08%

Operating Profit (PBDIT) excl Other Income

42,779.00

36,409.00

17.50%

Interest

102.00

57.00

78.95%

Exceptional Items

-892.00

-994.00

10.26%

Consolidate Net Profit

32,560.00

25,853.00

25.94%

Operating Profit Margin (Excl OI)

229.40%

211.70%

1.77%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 8.08% vs 2.83% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 25.94% vs 13.30% in Mar 2024

All Annual Results

Company CV

About Nippon Shinyaku Co., Ltd.

Nippon Shinyaku Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available